Navigation Links
Magnesium no benefit of survival after heart attack

According to researchers at the Hospital of Boston, a large clinical trial presents that giving intravenous magnesium after a heart attack does not improve survival after all. It has been assumed by some doctors that there could be benefit to patients// if they are given magnesium by infusion after a heart attack. The improvement in survival is thought to be especially significant for those who have had a specific type of heart attack known as ST-elevation myocardial infarction (STEMI).

Researchers from Brigham and Women's Hospital in Boston, USA, now report on a placebo-controlled trial of magnesium in 5,800 patients with acute STEMI. The death rate at 32 days for those given magnesium was 15.3 per cent, compared to 12.2 per cent for those on placebo. In other words, there is no survival benefit in giving magnesium for patients with this condition on a routine basis.


'"/>




Page: 1

Related medicine news :

1. Magnesium sulfate offers no help in migraine treatment
2. Magnesium In Diet Strengthens Bones
3. Magnesium Levels to Detect the Outcome of Brain Injury
4. Improved Wheats Could Reduce Magnesium Deficiencies: Research
5. Magnesium Supplements for Strong-boned Girls
6. India to benefit from pharma companies move
7. How do patients benefit of clinical trials
8. The earlier the treatment, the more the benefit
9. Women benefit from consuming fish
10. Possible benefits of Hormone Replacement Therapy
11. Approaching through Telemedicine benefits patients
Post Your Comments:
Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 1Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 2Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 3Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 1Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 2Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 3Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 4Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 5Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 6NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 1NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 2NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 3NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 4NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 5